poisar

Stocks · News reference

Wall Street Analysts Update Ratings and Price Targets for HCA Healthcare

Multiple financial institutions, including TD Cowen, Keybanc, Baird, and B of A Securities, updated their ratings and raised price targets for HCA Healthcare following recent financial results.

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

HCA
Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Na

    THC Q3 Earnings Beat on Hospital Strength, 2026 EPS View Raised

    Tenet Healthcare (THC) delivered robust third-quarter 2026 results with adjusted EPS of $6.64, up 79.5% year-over-year and beating estimates by 44.4%. Revenues grew 6.5% to $5.6 billion, driven by higher admissions, pricing strength, and disciplined cost management. The company raised its full-year 2026 adjusted EPS guidance to $22.05-$23.01 and EBITDA guidance to $5.05-$5.2 billion. Hospital EBITDA surged 34.8% to $818 million, while the company generated $1.1 billion in free cash flow and repurchased $255 million in shares.

    THCHCAELVUNH